bioRxiv Science⌕ Search

Biology subjects

Crawford, K. A.

Publications and source records attributed to Crawford, K. A..

3 recordsLinked to original sources

Deep learning-based codon optimization with large-scale synonymous variant datasets enables generalized tunable protein expression

Increasing recombinant protein expression is of broad interest in industrial biotechnology, synthetic biology, and basic research. Codon optimization is an important step in heterologous gene expression that can have dramatic effects on protein expression level. Several codon optimization strategies have been developed to enhance expression, but these are largely based on bulk usage of highly frequent codons in the host genome, and can produce unreliable results. Here, we develop deep contextual language models that learn the codon usage rules from natural protein coding sequences across members of the Enterobacterales order. We then fine-tune these models with over 150,000 functional expression measurements of synonymous coding sequences from three proteins to predict expression in E. coli. We find that our models recapitulate natural context-specific patterns of codon usage and can accurately predict expression levels across synonymous sequences. Finally, we show that expression predictions can generalize across proteins unseen during training, allowing for in silico design of gene sequences for optimal expression. Our approach provides a novel and reliable method for tuning gene expression with many potential applications in biotechnology and biomanufacturing.

synthetic biology↗

Spatiotemporal trends in polychlorinated biphenyl concentrations in seafood based on long-term monitoring and remediation in New Bedford Harbor, Massachusetts

Electrical manufacturing near New Bedford Harbor (NBH), MA in the mid-1900s led to severe polychlorinated biphenyl (PCB) contamination, which resulted in the harbors designation as a Superfund Site. Restrictions on the harvest of seafood from NBH have been in effect since 1979. Efforts to reduce the overall mass of PCBs in NBH by dredging PCB-contaminated sediments have been ongoing since the late 1980s. One goal of dredging is to reduce PCB concentrations in NBH seafood, monitored annually by Massachusetts Department of Environmental Protection (DEP) and Massachusetts Division of Marine Fisheries (MDMF). We used PCB concentrations in quahogs (2003-2016) and scup (2003-2014) to evaluate PCB distribution across seafood management areas and over time. Seafood PCB concentrations were used to evaluate improvements in environmental quality by examining total PCBs and patterns of PCB congeners within homolog groups, and by assessing human cancer risk from seafood consumption in the past (1980) and present (2012-2016). PCB concentrations in quahogs generally declined with increased time and distance from the PCB source, as does the cancer risk associated with their consumption. PCB concentrations in scup follow similar spatial patterns but show high annual variability. We conclude that quahogs are a reliable proxy for in-situ conditions, environmental quality, and human health risk.

ecology↗

MEK1/2 in Rhabdomyosarcoma

Alveolar and embryonal rhabdomyosarcoma (RMS) are soft-tissue cancers that affect children, adolescents, and young adults. Sometimes referred to as muscle cancer, RMS is a cancer of muscle and non-muscle origin that phenocopies incompletely differentiated myoblasts or activated satellite (muscle stem) cells. Interestingly, embryonal RMS (ERMS) has been observed to undergo terminal myogenic differentiation in response to stress induced by chemotherapy and radiation therapy4, 9, 24. Given the propensity of rhabdomyosarcoma to differentiation, in this report we explore the use of differentiation therapy combining MEK inhibitor (MEKi) cobimetinib and chemotherapy as a strategy to halt RMS growth. We evaluated a representative panel of RMS cell lines with cobimetinib and chemotherapy in two dosing schedules that mimic clinical use followed by cell growth evaluation and high content analysis (differentiation) assays. We uncovered that cobimetinib does not have significant additive or synergistic effects on cell differentiation or cell growth with chemotherapy in RMS and can have unanticipated antagonistic effects; specifically, pre-exposure of cobimetinib to cells can decrease the effectiveness of chemotherapy-mediated cell growth inhibition in vitro. Although differentiation-therapy is still a potential viable strategy in RMS, our data do not support MEKi/chemotherapy co-treatment in this context.

cancer biology↗